HIKMA PHARMACEUTICALS SAYS PLANS LONDON IPO

Generic drug company Hikma Pharmaceuticals said on Monday it planned to float on the London Stock Exchange with a price range of 265 to 330 pence, the middle of which values it at about 500 million pounds ($874.9 million).

Reuters (http://yahoo.reuters.com/financeQuoteCompanyNewsArticle.jhtml?duid=mtfh76110_2005-10-17_08-26-10_l17734419_newsml)